Risk of Production and Customer Activity Disruptions Due to the Spread of COVID-19
First written in FY2020. 5 of 13 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2025SoftenedAnnual report
「The impact of COVID-19 has now eased, due to the wider availability of vaccines and the reduced risk of severe illness resulting from viral mutations, among other factors, and socioeconomic activity has returned to normal.」
Regarding infectious disease risk, it reconfirms the normalization of socioeconomic activity and the reduction in impact, while retaining the possibility of a large-scale future spread of COVID-19 or a new infectious disease. - FY2024SoftenedAnnual report
「The impact of COVID-19 has now eased, due to the wider availability of vaccines and the reduced risk of severe illness resulting from viral mutations, among other factors, and socioeconomic activity has returned to normal. However, if COVID-19 or a new infectious disease spreads on a large scale in the future and disrupts the business activities of the Group companies and customers, the Group's operating results and financial condition may be affected.」
It explicitly states that the impact of COVID-19 has eased and socioeconomic activity has returned to normal, shifting the infectious disease risk from current actual impacts to the future risks of a resurgence or a new infectious disease. - FY2023SoftenedAnnual report
「Although the spread of COVID-19 is currently subsiding and countries are easing restrictions on movement, if the Group companies' and customers' business activities remain disrupted due to a resurgence of COVID-19 or the spread of a new infectious disease, the Group's operating results and financial condition may be affected.」
Regarding infectious disease risk, it describes the subsiding spread of infection and the easing of restrictions on movement, while retaining the possibility of a resurgence or a new infectious disease. - FY2023-Q3MaterialisedAnnual report
「In China, the number of infections rose sharply following a shift away from the zero-COVID policy, and infections occurred among employees of the Group's Chinese subsidiaries, but there was almost no impact on production.」
It states that infections occurred at a Chinese subsidiary, but had almost no impact on production. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter of the fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes to the business and other risks described for the previous fiscal year, including COVID-19. - FY2023-Q1RestatedAnnual report
「During the cumulative first quarter of the fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes to the business and other risks described for the previous fiscal year, including COVID-19. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes to the business and other risks described for the previous fiscal year, including COVID-19. - FY2022-Q1RestatedAnnual report
「During the cumulative first quarter of the fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the securities report for the previous fiscal year.」
It states that there have been no material changes to the business and other risks described for the previous fiscal year, including COVID-19. - FY2021MaterialisedAnnual report
「Revenue from precision machinery for the fiscal year was ¥8,675,946 thousand, down 1.5% from the previous fiscal year. Revenue from optical products was ¥6,142,083 thousand, down 11.3% from the previous fiscal year.」
The company disclosed as part of its full-year results that revenue declined in both the precision machinery-related and optical products-related segments due to the impact of COVID-19. - FY2021-Q3MaterialisedAnnual report
「However, in December 2020, several positive cases were identified at the domestic subsidiary 不二電子工業株式会社. Based on guidance from the public health center, the company disinfected the workplace and shared equipment, among other measures, and there was no impact on production.」
Regarding COVID-19, several positive cases actually occurred at a domestic subsidiary. The company explained that it disinfected the workplace and shared equipment, but there was no impact on production. - FY2021-Q2RestatedAnnual report
「In the information and communications and electronics-related markets in which our group operates, operating conditions deteriorated due to COVID-19, including the temporary shutdown of factories in various parts of the world. Even under these conditions, infrastructure development and expansion for optical communications progressed steadily ahead of the full-scale launch of 5G.」
The impact on business activities, including the temporary shutdown of factories around the world due to COVID-19, has continued. Meanwhile, the company states that sales at its Chinese subsidiary recovered rapidly after operations resumed. - FY2021-Q1MaterialisedAnnual report
「However, the subsidiaries in China and France were forced to temporarily suspend operations at the request of national or local governments. At the head office and domestic subsidiaries, we also implemented temporary furloughs lasting several days due to deteriorating customer operations and to prevent infections.」
The company states that, during the quarter, the subsidiaries in China and France actually suspended operations and the head office and domestic subsidiaries implemented temporary furloughs due to the spread of COVID-19. - FY2020First statedAnnual report
「From the beginning of 2020, COVID-19 infections spread and countries around the world implemented measures including restrictions on going out and travel and the suspension of business activities. Within our group, production activities at a consolidated subsidiary in China were temporarily halted, resulting in delays in shipments. Some customers also suspended operations, affecting the performance of our group.」
Regarding the spread of COVID-19, the company independently disclosed for the first time that production stoppages at its Chinese subsidiary, shipment delays, customer shutdowns and an impact on performance had actually occurred during the fiscal year as risks that materialized.